Category: Podcast

GoCheck Kids CEO Kevon Saber shares vision with pediatricians

published date
December 17th, 2020 by

Kevon Saber photo
Kevon Saber, GoCheck Kids CEO

Vision impairment is the most common disability for children, and it’s usually very treatable if detected early. But pediatricians struggle with vision screening. Wall charts are cumbersome to administer and as a result practices take shortcuts and miss a lot of cases. Kevon Saber is on a mission to change that. GoCheck Kids, where he’s CEO, uses a smartphone based tool for easy vision screening that integrates with the electronic health record.

In this episode of the HealthBiz Podcast, Kevon traces his journey as the son of Persian and Mexican parents living in immigrant neighborhoods, through Santa Clara University, Stanford, Silicon Valley and now Nashville. Many of the kids he grew up with have struggled –some are dead or in prison. Meanwhile, Kevon is a proponent of diversity in healthcare leadership, and wants his team to reflect the communities they serve.

Kevon is re-reading (or listening to) a few books:

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle Podcasts and  many more services. Please consider rating the podcast on Apple Podcasts. Doing so helps the podcast reach more listeners.

Check out the rough (AI generated) transcript of the episode. Click on a word if you want to start the podcast from a particular spot.


By healthcare business consultant David E. Williams, president of Health Business Group

Real-time patient feedback. Podcast interview with Feedtrail CEO Paul Jaglowski

published date
December 10th, 2020 by

Paul Jaglowski FeedTrail
FeedTrail CEO, Paul Jaglowski

Paul Jaglowski, CEO of Feedtrail has taken patient experience surveying to the next level, collecting real-time information from patients during their encounters. Big guys like Press Ganey, Qualtrics and NRC are looking over their shoulders at the new kid on the block.

Paul has gone from baseball player to management consultant to startup executive in a few short years. Along the way he’s collected a 30 under 30 award and contracted COVID-19. Thankfully he’s recovered in time to be in the running for 40 under 40.

For reading, he recommends The Hard Thing About Hard Things by Ben Horowitz (which was also recommended by previous guest Alex Zapesochny) and The Bottom Billion: Why the Poorest Countries are Failing and What Can Be Done About It, by Paul Collier.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle Podcasts and  many more services. Please consider rating the podcast on Apple Podcasts. Doing so helps the podcast reach more listeners.

Check out the rough (AI generated) transcript of the episode. Click on a word if you want to start the podcast from a particular spot.


By healthcare business consultant David E. Williams, president of Health Business Group

Healthcare is digital. Can interoperability be far behind? Podcast with Lyniate’s Drew Ivan

published date
December 3rd, 2020 by

Drew Ivan
Drew Ivan

With the digitization of health care records, you’d kind of expect that electronic medical records could talk to one another. Alas, the US healthcare system is still a veritable tower of Babel. It’s a real mess for patients, doctors, hospitals, labs, etc. trying to share information. And the pandemic has made things worse as people get testing and care in different places than they’re used to. Thanks to healthcare, the fax machine is still alive and well in the third decade of the 21st century.

But people like Drew Ivan haven’t given up. They’re working nonstop to turn the promise of healthcare interoperability into reality. As Chief Product and Strategy Officer of Lyniate, Drew is building digital connections throughout the healthcare ecosystem.

For your reading pleasure, he recommends Thinking in Bets: Making Smarter Decisions When You Don’t Have All the Facts by Annie Duke and the sequel, How to Decide: Simple Tools for Making Better Choices.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle Podcasts and  many more services. Please consider rating the podcast on Apple Podcasts. Doing so helps the podcast reach more listeners.

Check out the rough (AI generated) transcript of the episode. Click on a word if you want to start the podcast from a particular spot.


By healthcare business consultant David E. Williams, president of Health Business Group

Niall Brennan brings data to the healthcare party

published date
November 19th, 2020 by

Niall Brennan photo
HCCI CEO, Niall Brennan

Niall Brennan isn’t one to pull punches. From his perch as CEO of the Health Care Cost Institute he uses data to call out the moral and ethical failures of the US healthcare system. Insulin pricing, air ambulances, surprise billing, the pandemic. Whatever the topic, Brennan brings his sharp wit and deep reservoir of healthcare knowledge.

Before HCCI, Brennan was Chief Data Officer for the Center for Medicare and Medicaid Services and a staffer at Brookings, MedPac, the Congressional Budget Office and the Urban Institute. So his is the perspective of someone who knows what he’s talking about.

For reading, Niall recommends Say Nothing by Patrick Radden Keefe about the ‘Troubles’ in Northern Island and Let’s Go (So We Can Get Back), an autobiography by Wilco lead singer Jeff Tweedy.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle Podcasts and  many more services. Please consider rating the podcast on Apple Podcasts. Doing so helps the podcast reach more listeners.

Below is a rough (AI generated) transcript of the episode. Click on a word if you want to start the podcast from a particular spot.



By healthcare business consultant David E. Williams, president of Health Business Group

ICER founder Dr. Steve Pearson explains COVID-19 remdesivir pricing model

published date
November 12th, 2020 by

Steve scaled e1603726353244
Dr. Steve Pearson

Drug pricing is the hottest topic in healthcare, and ICER founder Dr. Steve Pearson is the coolest person to discuss it with.

In this episode of the HealthBiz podcast, Steve describes how the Institute for Clinical and Economic Review (ICER) compiles and analyzes clinical evidence to estimate the fair value of treatments for cancer and other serious illnesses. ICER has been especially active during the pandemic, developing a pricing model for remdesivir and other COVID-19 therapies that’s being used in the United States and by health technology assessment agencies around the world.

For fun, he has been reading Paradise Lost by John Milton.

This is the second episode I’ve recorded on COVID-19 drug pricing. Check out the first one: Remdesivir powers activate! with Dr. Surya Singh.

The HealthBiz podcast is now on SpotifyApple PodcastsGoogle Podcasts and  many more services, making it easy to subscribe.

Below is a rough (AI-generated) transcript of the episode.



—–

By healthcare business consultant David E. Williams, president of Health Business Group